HZHekmat Zarzour

Hekmat Zarzour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hekmat Zarzour has a total of 200 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decreasing Length of Stay in Elective Neurosurgery: Success of a Quality Improvement Initiative

    by Stavros Matsoukas, Teleale F. Gebeyehu, Jessica Canosa, Elizabeth Chiodi, Hekmat Zarzour, James S. Harrop, Richard F. Schmidt

  • Incidence and Predictors of Hemorrhagic Conversion After Mechanical Thrombectomy, Experience from a Large Comprehensive Stroke Center

    by Victor Gabriel El-Hajj, Maria Gharios, Joanna M. Roy, Basel Musmar, Deena Shefter, Christian Khoury, Wi Jin Kim, Michael Rizzuto, Nathaniel Ellens, Victor Romo, et al.

    BACKGROUND AND OBJECTIVES: Hemorrhagic conversion (HC) remains one of the most feared complications after mechanical thrombectomy (MT) for acute ischemic stroke and is associated with poor clinical outcomes. Evidence regarding predictors of HC after MT remains inconsistent. We sought to determine the incidence, predictors, and clinical impact of HC in a large contemporary cohort. METHODS: We conducted a retrospective analysis of a prospectively maintained database including consecutive patients who underwent MT for acute ischemic stroke between January 2016 and December 2024. Baseline clinical, radiographical, and procedural variables were collected. Outcomes were compared between patients with and without HC using 1:1 propensity score matching. Multivariable logistic regression was performed to identify independent predictors of HC. RESULTS: Among 896 patients undergoing MT, 267 (29.8%) experienced HC. After propensity score matching, HC remained associated with worse discharge neurological status (National Institutes of Health Stroke Scale 12.7 vs 9.6; P = .013), longer hospital length of stay (12.3 vs 9.9 days; P = .004), higher rates of decompressive craniectomy (9.4% vs 2.2%; P < .001), and increased likelihood of nonhome discharge (83% vs 71%; P < .001). In-hospital mortality was not significantly different after matching. On multivariable analysis, independent predictors of HC included higher admission National Institutes of Health Stroke Scale score (odds ratio [OR]: 1.04), diabetes mellitus (OR: 2.08), chronic kidney disease (OR: 1.76), and ≥3 thrombectomy passes (OR: 1.75). Increasing age (OR: 0.98), Black race (OR: 0.61), stent-retriever alone thrombectomy (OR: 0.53), and posterior circulation strokes (OR: 0.27) were all significantly associated with lower odds of HC. CONCLUSION: HC occurs in approximately one-third of patients undergoing MT and is independently associated with substantial neurological morbidity and healthcare utilization. Stroke severity, metabolic comorbidities, stroke location, and procedural complexity are key determinants of hemorrhagic risk. These findings support the need for enhanced risk stratification, and heightened postprocedural vigilance in high-risk patients.

  • The impact of BMI on mechanical thrombectomy outcomes, insights from a comprehensive stroke center

    by Victor Gabriel El-Hajj, Basel Musmar, Joanna M. Roy, Maria Gharios, Wi Jin Kim, Michael Rizzuto, Nathaniel Ellens, Stavropoula Tjoumakaris, M. Reid Gooch, Robert H. Rosenwasser, et al.

    Identifying predictors of outcomes following mechanical thrombectomy (MT) for stroke is crucial for selecting patients most likely to benefit from the treatment as well as guiding prognostication efforts. When it comes to the role of Body Mass Index (BMI) as a prognostic marker in that context, the evidence is conflicting. A retrospective analysis of a prospectively maintained database including patients undergoing MT between the 2016 and 2024 was performed. The main outcomes were functional recovery (discharge modified Rankin Scale (mRS); < 3 vs. ≥3), discharge National Institute of Health Stroke Scale (NIHSS) score, and in-hospital mortality. Multivariable regression and propensity score matching (PSM) were used. A total of 894 patients were included: 16 (1.8%) underweight, 298 (33%) normal weight, 291 (33%) overweight, and 289 (32%) obese (18% class 1, 8.8% class 2, and 4.9% class 3 obesity). On adjusted multivariable regression analyses, none of the BMI categories were associated with discharge mRS (p ≥ 0.05). However, underweight status was an independent positive predictor of both discharge NIHSS score (β = 8.5, 95% CI 3.5–14, p = 0.001), and in-hospital mortality (OR = 6.27, 95% CI 0.95–34.4, p = 0.040). No associations between either discharge NIHSS score or mortality and other BMI categories could be found (p ≥ 0.05). After PSM, no differences in terms of technical difficulty, including number of thrombectomy attempts, length of procedure, and reperfusion success, could be established on the basis of BMI (p ≥ 0.05). While obesity was associated with comparable outcomes compared to normal BMI, underweight status was shown to independently worsen outcomes following MT for stroke. Further studies are needed to establish the nature of this association.

  • Telescoping Flow Diverters for the Treatment of Brain Aneurysms: Indications and Outcome

    by Joanna M. Roy, Kareem El Naamani, Arbaz A. Momin, Marc Ghanem, Matthews Lan, Meah T. Ahmed, Sarah Winiker, Eric M. Teichner, Basel Musmar, Stavropoula I. Tjoumakaris, et al.


  • Open Access

    E-124 Flow diversion for giant cavernous internal carotid artery aneurysms: a case series of nine patients

    by K El Naamani, S Majmundar, R Abbas, N Herial, H Zarzour, R Schmidt, S Tjoumakaris, R Rosenwasser, P Jabbour, M Gooch, et al.

    Background Giant internal carotid artery (ICA) aneurysms in the cavernous segment can cause mass effect and a variety of cranial nerves palsies. With the introduction of flow diverting stents, a new option was added to the treatment paradigm. Objective To assess efficacy, feasibility, and safety profile of flow diverters in treating giant ICA aneurysms. Methods This is a retrospective case-series of giant cavernous aneurysms treated with flow diversion between 2012 and 2022 at our institution. Giant aneurysms were defined as aneurysms with a maximal diameter of ≥24mm. Results Our case series comprised of 9 female patients with a mean age of 66.8 years ± 14.1. The mean aneurysm neck width was 7.1 mm ±1.5, mean maximal diameter was 25.1 mm ±4.9, and mean height was 18. 5 mm ± 7.2. Only 1 (11.1%) patient who presented with a ruptured aneurysms on admission, experienced a re-rupture during the post-operative duration and passed away. At final follow-up, 6 (85.7%) patients achieved complete aneurysm occlusion (RROC Grade I), 1 (14.3%) patient had a neck residue (RROC Grade II), recurrence rate was 0% and all patients had good functional outcome (mRS 0-2). The mean duration to final follow-up was 28.3 months ± 27.2. Conclusion Compared to other endovascular and surgical techniques, flow diversion for giant cavernous ICA aneurysms can be a safe and effective treatment option. Further larger studies should be conducted to validate and strengthen our results. Disclosures K. El Naamani: None. S. Majmundar: None. R. Abbas: None. N. Herial: None. H. Zarzour: None. R. Schmidt: None. S. Tjoumakaris: 2; C; Medtronic, Microvention. R. Rosenwasser: None. P. Jabbour: 2; C; Medtronic, Microvention, Balt, Cerus Endovascular. M. Gooch: None. L. Mackenzie: None. O. Kozak: None. V. Schunemann: None.

  • Open Access

    E-115 Trans-radial versus trans-femoral access routes for diagnostic cerebral angiograms: a large single-center comparative cost-analysis study

    by K El Naamani, E Atallah, A Momin, P Jain, A Hunt, A Sambangi, A Carreras, O El Fadel, M Gooch, S Tjoumakaris, et al.

    Background Cerebral angiography has long been established as the gold standard modality to diagnose and treat cerebral vascular pathologies. Conventionally, the trans-femoral approach has been well established in neuro-interventional community for such procedures. Recently, the trans-radial approach has become a common alternative given its safety profile and increased patient satisfaction compared to the transfemoral route. Both routes are associated with their respective associated costs and differences typically emerge based on patients’ anatomy, operator expertise, and occurrence of complications. Objective In this study, we aim to compare and evaluate the overall costs of diagnostic cerebral angiography for both routes and shed light on individual equipment cost for each route.Methods: This a retrospective single-center study of 926 elective diagnostic angiograms performed between December 2019 and March 2022. Results The study comprised of 314 and 612 angiograms done through the TF and TR routes respectively. Female patients were significantly higher in the TF cohort (79.3% vs 67.8%, p<.001), and most other demographic characteristics and baseline modified Rankin Scale score were comparable between both cohorts. Similarly, the number of devices used was comparable between both groups. The overall cost of patients utilizing the TR route was comparable to that of the TF route (12591.8$ ±19128 vs 12789.5$ ± 18424, p=.88). However, the median cost of catheters was significantly higher in TR group (55.2$ vs 12.4$, p=.03), while the median cost of closure devices (87$ vs 20.2$ p<.001), and sheaths (44.6$ ± 11.3 vs 41.1$ ± 3.1, p<.001) was significantly higher in the TF group. Conclusion Overall, our study shows that the TR approach can be less a less expensive option for patients undergoing diagnostic cerebral angiograms, especially if complications occur. Future studies can corroborate our findings and potentially lead to the adoption of TR as a low-cost, efficient, gold-standard technique for cerebral angiography. Costs (dollars) Associated with Trans-Radial Versus Trans-Femoral Access Disclosures K. El Naamani: None. E. Atallah: None. A. Momin: None. P. Jain: None. A. Hunt: None. A. Sambangi: None. A. Carreras: None. O. El Fadel: None. M. Gooch: 2; C; Stryker. S. Tjoumakaris: 2; C; Microvention, Medtronic. H. Zarzour: None. R. Schmidt: None. N. Herial: None. R. Rosenwasser: None. P. Jabbour: 2; C; Microvention, Medtronic, Balt, Cerus Endovascular.


  • Open Access

    E-212 A comparison of outcomes between transfemoral versus transradial access for carotid stenting

    by K El Naamani, O Khanna, A Syal, A Momin, R Abbas, A Amllay, A Sambangi, A Hunt, J Dougherty, C Lawall, et al.

    Background The transradial (TR) approach has emerged as an alternative to the transfemoral (TR) approach in carotid artery stenting (CAS) due to its perceived benefits in access site complications and overall patient experience. Objective To assess outcomes of transfemoral vs transradial approach for carotid artery stenting. Methods This is a retrospective single-center review of patients receiving CAS via the TR or TF route between 2017 and 2022. All patients with symptomatic and asymptomatic carotid disease who underwent attempted CAS were included in our study. Results A total of 342 patients are included in the study: 232 underwent CAS via TF approach vs 110 via the TR route. On univariate analysis, the rate of overall complications was more than double for the TF vs TR cohort, however this did not achieve statistical significance (6.5%vs2.7%, OR=0.59 p=.36). The rate of cross-over from TR to TF was significantly higher on univariate analysis (14.6%vs2.6%, OR=4.77, p=.005) and on inverse probability treatment weighting analysis (OR= 6.11, p<.001). The rate of in-stent stenosis (TR:3.6% vs TF:2.2%, OR=1.71, p=.43) and strokes at follow-up (TF:2.2% vs TR:1.8%, OR= 0.84, p=.84) was not significantly different. Lastly, median length of stay was comparable between both cohorts. Conclusion The TR approach is safe, feasible, and provides similar rates of complications and high rates of successful stent deployment compared with the TF route. Neurointerventionalists adopting the radial first approach should carefully assess the pre-procedural computed tomography angiography to identify patients amenable to TR approach for carotid stenting. Comparison of outcomes between trans-radial vs trans-femoral access Disclosures K. El Naamani: None. O. Khanna: None. A. Syal: None. A. Momin: None. R. Abbas: None. A. Amllay: None. A. Sambangi: None. A. Hunt: None. J. Dougherty: None. C. Lawall: None. S. Tjoumakaris: 2; C; Microvention, Medtronic. M. Gooch: 2; C; Stryker. N. Herial: None. R. Rosenwasser: None. H. Zarzour: None. R. Schmidt: None. P. Jabbour: 2; C; Microvention, Medtronic, Balt, Ceres Endovascular.

  • Open Access

    E-086 The effect of covid-19 vaccines on stroke outcomes: a single-center study

    by K El Naamani, A Amllay, C Chen, S Capone, R Abbas, G Sioutas, A Munoz, C Yudkoff, A Carreras, A Samabngi, et al.

    Background One of the defining narratives of the COVID-19 pandemic has been the acceptance and distribution of vaccine. Objective Compare the outcomes of COVID-19 positive vaccinated and unvaccinated stroke patients. Methods This is a single-center retrospective study of COVID-19-vaccinated and unvaccinated stroke patients between April 2020 and March 2022. All patients presenting with stroke regardless of treatment modalities were included. NIHSS was used to assess stroke severity. The primary outcome was functional capacity of the patients at discharge. Results The study cohort comprised 203 COVID-19 positive stroke patients divided into 139 unvaccinated and 64 fully vaccinated patients. At discharge, the mRS score was significantly lower in the vaccinated cohort (3[1-4] vs 4[2-5], OR=0.508, p=0.011). At 3 months of follow-up, the median mRS score was comparable between both cohorts. Conclusion Although vaccination did not show any significant difference in stroke patient outcomes on follow-up, vaccines were associated with lower rates of morbidity and mortality at discharge among stroke patients during the pandemic. Comparison of outcomes between COVID-19-positive unvaccinated vs. fully vaccinated patients presenting with stroke.*Adjusted for hypertension, atrial fibrillation, PVD, admission NIHSS, ASPECTS, tandem occlusion, and thrombectomy Disclosures K. El Naamani: None. A. Amllay: None. C. Chen: None. S. Capone: None. R. Abbas: None. G. Sioutas: None. A. Munoz: None. C. Yudkoff: None. A. Carreras: None. A. Samabngi: None. A. Hunt: None. P. Jain: None. E. Stine: None. A. Sathe: None. R. Smit: None. F. Yazbeck: None. S. Tjoumakaris: 2; C; Mivrovention, Medtronic. M. Gooch: 2; C; Stryker. N. Herial: None. R. Rosenwasser: None. H. Zarzour: None. R. Schmidt: None. M. El Ghanem: None. P. Jabbour: 2; C; Medtronic, Microvention, Balt, Cerus Endovascular.

  • Long-Term Follow-Up of Cerebral Aneurysms Completely Occluded at 6 Months After Intervention with the Woven EndoBridge (WEB) Device: a Retrospective Multicenter Observational Study

    by Kareem El Naamani, Panagiotis Mastorakos, Nimer Adeeb, Mathews Lan, James Castiglione, Omaditya Khanna, Jose Danilo Bengzon Diestro, Rachel M. McLellan, Mahmoud Dibas, Justin E. Vranic, et al.

    The Woven EndoBridge (WEB) device has been widely used to treat intracranial wide neck bifurcation aneurysms. Initial studies have demonstrated that approximately 90% of patients have same or improved long-term aneurysm occlusion after the initial 6-month follow up. The aim of this study is to assess the long-term follow-up in aneurysms that have achieved complete occlusion at 6 months. We also compared the predictive value of different imaging modalities used. This is an analysis of a prospectively maintained database across 13 academic institutions. We included patients with previously untreated cerebral aneurysms embolized using the WEB device who achieved complete occlusion at first follow-up and had available long-term follow-up. A total of 95 patients with a mean age of 61.6 ± 11.9 years were studied. The mean neck diameter and height were 3.9 ± 1.3 mm and 6.0 ± 1.8 mm, respectively. The mean time to first and last follow-up was 5.4 ± 1.8 and 14.1 ± 12.9 months, respectively. Out of all the aneurysms that were completely occluded at 6 months, 84 (90.3%) showed complete occlusion at the final follow-up, and 11(11.5%) patients did not achieve complete occlusion. The positive predictive value (PPV) of complete occlusion at first follow was 88.4%. Importantly, this did not differ between digital subtraction angiography (DSA), magnetic resonance angiography (MRA), or computed tomography angiography (CTA). This study underlines the importance of repeat imaging in patients treated with the WEB device even if complete occlusion is achieved short term. Follow-up can be performed using DSA, MRA or CTA with no difference in positive predictive value.


  • Woven EndoBridge versus stent-assisted coil embolization of cerebral bifurcation aneurysms

    by Kareem El Naamani, Ching-Jen Chen, Rawad Abbas, Ahmad Sweid, Georgios S. Sioutas, Khodr Badih, Sunidhi Ramesh, Stavropoula I. Tjoumakaris, M. Reid Gooch, Nabeel A. Herial, et al.

    OBJECTIVE: Stent-assisted coil (SAC) embolization has been the mainstay endovascular treatment for bifurcation aneurysms. The recent introduction of the Woven EndoBridge (WEB) device has presented an alternative endovascular treatment modality for these aneurysms. Direct comparisons of outcomes between these two modalities are limited in the literature. Here, the authors compared the outcomes of bifurcation aneurysms treated with SAC and WEB devices. METHODS: This retrospective single-center study comprised 148 bifurcation aneurysms that were treated endovascularly with SAC or WEB devices between 2011 and 2019. The primary outcome was complete occlusion of the aneurysm at 6 months on catheter angiography. RESULTS: The SAC and WEB cohorts comprised 85 and 63 aneurysms, respectively. The baseline characteristics were well balanced after inverse probability weight (IPW) adjustment, except for smoking status. The 6-month complete occlusion rate was higher in the WEB cohort than the SAC cohort (67.4% vs 40.6%; unadjusted OR [95% CI] 3.014 [1.385–6.563], p = 0.005). However, this difference in complete occlusion rates did not remain significant after IPW adjustment and multiple imputations. The neck remnant rate was lower in the WEB cohort than the SAC cohort (20% vs 50%; OR [95% CI] 0.250 [0.107–0.584], p = 0.001), and this difference remained significant after IPW adjustment (OR [95% CI] 0.304 [0.116–0.795], p = 0.015) and multiple imputations. CONCLUSIONS: Use of SAC and WEB demonstrated comparable 6-month complete occlusion rates for bifurcation aneurysms. WEB appeared to be associated with a lower rate of neck remnant at 6 and 12 months compared with SAC. WEB was also associated with fewer complications and decreased retreatment rates compared with SAC.